|
HY-112815-50mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-117727A-5mg
|
MedChemexpress LLC
|
Leriglitazone (hydrochloride) [CAS 146062-46-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-122652-100mg
|
MedChemexpress LLC
|
MitoBloCK-6 [CAS 303215-67-0]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-122652-25mg
|
MedChemexpress LLC
|
MitoBloCK-6 [CAS 303215-67-0]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-122652-50mg
|
MedChemexpress LLC
|
MitoBloCK-6 [CAS 303215-67-0]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-125286-1mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-10mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-100mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-25mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-5mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-50mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-134188-1mg
|
MedChemexpress LLC
|
JNJ-54717793 [CAS 1628843-99-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134188-10mg
|
MedChemexpress LLC
|
JNJ-54717793 [CAS 1628843-99-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134188-100mg
|
MedChemexpress LLC
|
JNJ-54717793 [CAS 1628843-99-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134188-25mg
|
MedChemexpress LLC
|
JNJ-54717793 [CAS 1628843-99-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134188-5mg
|
MedChemexpress LLC
|
JNJ-54717793 [CAS 1628843-99-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134188-50mg
|
MedChemexpress LLC
|
JNJ-54717793 [CAS 1628843-99-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14442-5mg
|
MedChemexpress LLC
|
ML 10302 (hydrochloride) [CAS 186826-17-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-14855-10mg
|
MedChemexpress LLC
|
Tedizolid [CAS 856866-72-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-14855-5mg
|
MedChemexpress LLC
|
Tedizolid [CAS 856866-72-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-14855-50mg
|
MedChemexpress LLC
|
Tedizolid [CAS 856866-72-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-16677A-10mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-16677A-100mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-16677A-5mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-16677A-50mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
